• Blog
  • GI Stool Testing Market Report

    GI Stool Testing Market Report

    GI Stool Testing Market Report
    Report code - SRHL212 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    Global GI Stool Testing Market, Dynamics, Market Analysis
    See more...

    Market Insights

    The Global GI Stool Testing Market is projected to grow from USD xx million in 2020 to USD xx million by 2026 at a CAGR of over 7.4% during the forecast period.

    Figure: Global GI Stool Testing Market Size, 2020-2026 (USD Million)

    GI-Stool-Testing-Market-Forecast

    Wish to get a free sample? Register Here

    What is Gastrointestinal (GI) stool testing?

    Gastrointestinal (GI) disorders are highly common among the populace and can cause severe harm to digestive health. GI stool testing is the diagnosis of stool or feces samples to detect or analyze digestive tract diseases or infections. GI disorders consist of various diseases such as malabsorption, bowel inflammation, and cancer, among others. These tests are performed to diagnose GI tract disorders and help in the detection of parasite infection and bleeding obstruction.

    Key Players

    Key players operating in the global GI stool testing market are-

    • Abbott Laboratories (The US),
    • Beckman Coulter Inc. (The US),
    • bioMerieux SA (France),
    • Cardinal Health (The US),
    • Cenogenics Corporation (The US),
    • CTK Biotech Inc. (The US),
    • Genova Diagnostics (The US),
    • Epitope Diagnostics Inc. (The US),
    • ScheBo Biotech AG (Germany), and
    • MERIDIAN BIOSCIENCE INC. (The US).

    Market Dynamics

    The growing healthcare awareness and rising healthcare expenditure by the government & private sector are likely to bolster the product demand.

    • The increasing prevalence of GI health disorders owing to rising consumption of fast food, stress & hectic lifestyle, as well as the growing geriatric population who are highly susceptible to GI infections, are some of the factors proliferating the market growth.
    • Furthermore, significant R&D investment in the field of GI stool testing is expected to offer lucrative opportunities to the market participants.
    • However, stringent rules & regulations associated with GI stool testing and lack of skilled personnel are some of the restraining factors impacting the market growth.

    Segment Analysis

    Product Trends

    Based on the product, the global GI stool testing market has been bifurcated into instruments and reagents.

    • Among these, the reagents segment accounted for the highest market share in 2020 and is likely to register a steady CAGR during the review period.
    • Reagents are substances used for analyzing and examining the stools.
    • They are specific biological components that have the superior ability to detect the presence of pathogenic agents in a patient’s blood sample, thus growing GI disordered results in segment growth.

    Regional Trends

    By region, the North America market witnessed the highest market share in 2020 and is projected to grow at a robust CAGR during the review period.

    • This can be attributed to rising healthcare expenditure, presence of major healthcare companies, rising fast food consumption, changing lifestyle, and increasing senior population, promulgate the product region in the region.
    • Moreover, rising consumer awareness, FDA approvals for GI stool tests and instruments, and increasing product launches further boosts the regional growth.

    COVID-19 Impact on Global GI Stool Testing Market

    The COVID-19 pandemic has significantly affected the GI stool testing industry due to the shift of medical treatment from gastrointestinal disorders towards soaring coronavirus-affected patients. Moreover, the healthcare expenditure has been used for the production of the COVID-19 vaccine, resulting in less R&D in product innovation. Also, the appointments of the GI disorder patients were either delayed or postponed, thus affecting the market growth.

    Want to know the full scope of the report? Register Here

    Critical Questions Answered in the Report

    • What are the key trends in the global GI stool testing market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the global GI stool testing market?
    • What are the key strategies adopted by the major vendors to lead in the global GI stool testing market?
    • What is the market share of the top vendors?

    Target Audience

    Here is the list of the group of customers that the GI Stool testing market hopes to have the greatest opportunity to convert-

    • GI stool testing companies
    • Hospitals
    • Diagnostic Centers And Laboratories
    • Academic Institutions
    • Research Centers & Organizations

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].

    Frequently Asked Questions (FAQs)

    The GI stool testing market is expected to witness an impressive growth of 7.4% CAGR in the foreseeable future.

    Abbott Laboratories (The US), Beckman Coulter Inc. (The US), bioMerieux SA (France), Cardinal Health (The US), Cenogenics Corporation (The US), CTK Biotech Inc. (The US), Genova Diagnostics (The US), Epitope Diagnostics Inc. (The US), ScheBo Biotech AG (Germany), and MERIDIAN BIOSCIENCE INC. (The US) are among the key players in the GI stool testing market.

    The growing healthcare awareness and rising healthcare expenditure by the government & private sector, The increasing prevalence of GI health disorders owing to rising consumption of fast food, stress & hectic lifestyle, as well as the growing geriatric population who are highly susceptible to GI infections are the factors driving the growth of GI stool testing market.

    North America market witnessed the highest market share in 2020 and is projected to grow at a robust CAGR during the review period.

    The reagents segment accounted for the highest market share in 2020 and is likely to register a steady CAGR during the review period.

    GI stool testing companies, Hospitals, Diagnostic Centers And Laboratories, Academic Institutions, Research Centers & Organizations are the target audience in the GI stool testing market.

    •